Daniela Goyes
Overview
Explore the profile of Daniela Goyes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alsaqa M, Sierra L, Marenco-Flores A, Parraga X, Barba R, Goyes D, et al.
Eur J Gastroenterol Hepatol
. 2025 Feb;
PMID: 39976068
Background: Direct-acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment. The changing landscape of hepatocellular carcinoma (HCC) in liver transplant (LT) recipients lacks a thorough description of the outcomes...
2.
Idalsoaga F, Diaz L, Guizzetti L, Dunn W, Mehta H, Arnold J, et al.
Aliment Pharmacol Ther
. 2025 Feb;
PMID: 39967231
Several dynamic models predict mortality and corticosteroid response in alcohol-associated hepatitis (AH), yet no consensus exists on the most effective model. This study aimed to assess predictive models for corticosteroid...
3.
Amaris N, Marenco-Flores A, Barba R, Rubio-Cruz D, Medina-Morales E, Goyes D, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597786
: Acute liver failure (ALF) involves rapid liver injury, often leading to multi-organ failure. Liver transplantation (LT) has improved survival rates, with U.S. rates reaching 92%. This study analyzes UNOS...
4.
Marenco-Flores A, Amaris N, Kahan T, Sierra L, Barba Bernal R, Medina-Morales E, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124763
The cornerstone treatment for primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA), but many patients exhibit an incomplete response, leading to disease progression. Risk prediction models like the GLOBE and...
5.
Goyes D, Niezen S, Rubianes-Guerrero M, Barba R, Sierra L, Bonder A
Clin Liver Dis (Hoboken)
. 2024 Jul;
23(1):e0240.
PMID: 38961876
No abstract available.
6.
Niezen S, Goyes D, Vipani A, Yang J, Ayoub W, Kuo A, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892917
The Hispanic population in the US faces a higher risk of nonalcoholic fatty liver disease (NAFLD). Multiple factors influence this risk, including genetics, environmental factors, and socioeconomic statuses. Inadequate access...
7.
Marenco-Flores A, Sierra L, Goyes D, Kahan T, Patwardhan V, Bonder A
Clin Liver Dis (Hoboken)
. 2024 Jun;
23(1):e0187.
PMID: 38872783
No abstract available.
8.
Cessa-Zanatta J, Cortez-Hernandez C, Goyes D, Bonder A
Clin Liver Dis (Hoboken)
. 2024 Feb;
23(1):e0089.
PMID: 38379766
No abstract available.
9.
Sierra L, Marenco-Flores A, Barba R, Goyes D, Ferrigno B, Diaz W, et al.
Ann Hepatol
. 2023 Dec;
29(3):101283.
PMID: 38151060
Introduction And Objectives: Autoimmune liver diseases (AILDs): autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) have different survival outcomes after liver transplant (LT). Outcomes are influenced...
10.
Medina-Morales E, Ismail M, Barba Bernal R, Abboud Y, Sierra L, Marenco-Flores A, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892674
Primary biliary cholangitis (PBC) prompts liver transplantation (LT) due to cholestasis, cirrhosis, and liver failure. Despite lower MELD scores, recent studies highlight higher PBC waitlist mortality, intensifying the need for...